(HuaShen Technology): Intends to privately place up to 111 million shares to Yuanhong Biology, and the controlling shareholder will change to a joint controlling shareholder.

Huashen Technology Announcement: The company plans to issue no less than 95.2381 million shares and no more than 111 million shares to Chengdu Yuanhong Biotechnology Co., Ltd., all of which will be subscribed in cash by Yuanhong Biotechnology. According to the calculation of the upper limit of the issuance, after the issuance is completed, the controlling shareholder of the company will change from Sichuan Huashen Group Co., Ltd. to be Sichuan Huashen and Yuanhong Biotechnology as co-controlling shareholders. The total shareholding ratio of Yuanhong Biotechnology and persons acting in concert will increase from 17.87% to 30.28%, and the actual controller will still be Huang Mingliang and Ouyang Ping. This issuance is subject to approval by the Shenzhen Stock Exchange and registration approval by the China Securities Regulatory Commission.